ÂÜŔňÂŇÂ×

Barbara L. Powers, MSN, Ph.D., is Vice President, Clinical Operations of Clear Creek Bio, joining the company in August of 2017. Barbara earned her bachelor’s degree in nursing at the University of Delaware, followed by a Master of Science in Nursing from the University of Pennsylvania. She holds a Ph.D. from Temple University. Her life-long love of medicine began as a candy striper volunteer at a local hospital. Although giving up direct patient care was difficult, Barbara realized that while she could directly help a few patients as a nurse, but as a researcher, she could help many more. She has led the clinical effort for 15 INDs and managed multiple clinical trials from first-in-human to large, multicenter, global Phase 3b studies.

Barbara founded Expedite Research, a pharmaceutical and medical device consulting company in 2013. Prior to Expedite Research, Barbara was Vice President, Clinical Development of Cytokine PharmaSciences, a privately held, global biopharmaceutical company developing controlled-release drug delivery products in women’s health and small molecule therapeutics in the areas of autoimmune diseases, anti-inflammation, and cancer. While at Cytokine, Barbara led the clinical effort for phase 1, 2, and 3 studies resulting in a global submission for a labor induction product approved in 54 countries. Barbara also led the clinical team at Neuron Therapeutics, a start-up company focused on developing a novel drug/device combination product for treating ischemic stroke and subarachnoid hemorrhage. Barbara worked for Rhône-Poulenc Rorer (now Sanofi Aventis) for 14 years where she was instrumental in establishing the Clinical Operations group as Associate Director of Clinical Operations and Worldwide Resource Allocation, managing a team of 130 CRAs in 10 countries.

Barbara’s clinical experience of 10 years working in Labor & Delivery taught her how to prioritize and stay calm in a crisis.